Talis Biomedical Corp Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Talis Biomedical Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
  • Talis Biomedical Corp Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$8.85M, a 41.1% increase year-over-year.
  • Talis Biomedical Corp Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$51M, a 40.5% increase year-over-year.
  • Talis Biomedical Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$62M, a 45.1% increase from 2022.
  • Talis Biomedical Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$113M, a 41.2% increase from 2021.
  • Talis Biomedical Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$192M, a 111% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$62M +$51M +45.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$113M +$79M +41.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$192M -$101M -111% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 -$91.1M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.